Electronic Patient Information Leaflets Are The Future, But Paper Not Going Away Any Time Soon
Executive Summary
European industry and regulators are looking to electronic patient information leaflets (ePILs) as a way to better support consumers to safely use OTC medicines. However, paper leaflets are here to stay for the foreseeable future, according to the European Commission.
You may also be interested in...
AESGP Welcomes EU Pharma Revision But Warns Of ‘Unintended Negative Consequences’
European self-care industry association AESGP says it supports the revision of the EU pharmaceutical legislation “in principle,” but has concerns that some of the proposals “may have unintended negative consequences.”
Self-Care Medical Devices Sitting In The ‘Danger Zone,’ AESGP Warns
The Association of the European Self-Medication Industry (AESGP) warns that many self-care medical devices could fall through the cracks of implementing new EU regulations, as the deadline draws near.
EMA Is Exploring How Real-World Data Can Benefit Europe’s OTC Market, Says Agency Head Rasi
The European Medicines Agency is right now looking into how real-world data and evidence can be used to improve regulatory systems and extend access to OTC medicines within the European Union, the agency's executive director Guido Rasi told the recent AESGP Regulatory Conference in Amsterdam.